<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem Ltd has submitted an initial disclosure filing to BSE and NSE confirming that it does not meet the criteria to be classified as a 'Large Corporate' under SEBI regulations. As of March 31, 2026, the company had outstanding borrowings of Rs. 6.04 crores. The company holds CRISIL BBB+/Stable rating for long-term debt and CRISIL A2 for short-term debt. Since the company is not classified as a Large Corporate, it is not subject to mandatory borrowing requirements through debt securities, and the fine provision for shortfalls is not applicable.
This filing is a routine regulatory compliance submission with no direct impact on shareholders. The confirmation that Tatva Chintan is not a Large Corporate means it does not face mandatory debt market borrowing obligations, and its relatively low debt level of Rs. 6.04 crores with investment-grade ratings reflects a conservative capital structure.